125 related articles for article (PubMed ID: 6631230)
1. Isoproteins of human apolipoprotein A-II: isolation and characterization.
Schmitz G; Ilsemann K; Melnik B; Assmann G
J Lipid Res; 1983 Aug; 24(8):1021-9. PubMed ID: 6631230
[TBL] [Abstract][Full Text] [Related]
2. Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteins.
Rosseneu M; Assmann G; Taveirne MJ; Schmitz G
J Lipid Res; 1984 Feb; 25(2):111-20. PubMed ID: 6423754
[TBL] [Abstract][Full Text] [Related]
3. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
Kay LL; Ronan R; Schaefer EJ; Brewer HB
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
[TBL] [Abstract][Full Text] [Related]
4. The lipid transport system in the mouse, Mus musculus: isolation and characterization of apolipoproteins B, A-I, A-II, and C-III.
Forgez P; Chapman MJ; Rall SC; Camus MC
J Lipid Res; 1984 Sep; 25(9):954-66. PubMed ID: 6436419
[TBL] [Abstract][Full Text] [Related]
5. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
Schmitz G; Assmann G; Rall SC; Mahley RW
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
[TBL] [Abstract][Full Text] [Related]
6. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins.
Higuchi K; Yonezu T; Kogishi K; Matsumura A; Takeshita S; Higuchi K; Kohno A; Matsushita M; Hosokawa M; Takeda T
J Biol Chem; 1986 Sep; 261(27):12834-40. PubMed ID: 3091606
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
Guyard-Dangremont V; Lagrost L; Gambert P
J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of apolipoproteins A-I, A-II, and A-IV.
Brewer HB; Ronan R; Meng M; Bishop C
Methods Enzymol; 1986; 128():223-46. PubMed ID: 3088390
[TBL] [Abstract][Full Text] [Related]
10. Spur cells in patients with alcoholic liver cirrhosis are associated with reduced plasma levels of apoA-II, HDL3, and LDL.
Duhamel G; Forgez P; Nalpas B; Berthelot P; Chapman MJ
J Lipid Res; 1983 Dec; 24(12):1612-25. PubMed ID: 6421974
[TBL] [Abstract][Full Text] [Related]
11. Human proapolipoprotein A-I: development of an antibody to the propeptide as a probe of apolipoprotein A-I biosynthesis and processing.
Hospattankar AV; Fairwell T; Appella E; Meng M; Brewer HB
Biochem Biophys Res Commun; 1987 Nov; 149(1):289-96. PubMed ID: 3120726
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
[TBL] [Abstract][Full Text] [Related]
13. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
Schaefer EJ; Kay LL; Zech LA; Brewer HB
J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
[TBL] [Abstract][Full Text] [Related]
14. In vivo metabolism of proapolipoprotein A-I in Tangier disease.
Bojanovski D; Gregg RE; Zech LA; Meng MS; Bishop C; Ronan R; Brewer HB
J Clin Invest; 1987 Dec; 80(6):1742-7. PubMed ID: 3119665
[TBL] [Abstract][Full Text] [Related]
15. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films.
Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ
Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Alaupovic P; Knight-Gibson C; Wang CS; Downs D; Koren E; Brewer HB; Gregg RE
J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345
[TBL] [Abstract][Full Text] [Related]
18. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
[TBL] [Abstract][Full Text] [Related]
19. Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis.
Visvikis S; Dumon MF; Steinmetz J; Manabe T; Galteau MM; Clerc M; Siest G
Clin Chem; 1987 Jan; 33(1):120-2. PubMed ID: 3100093
[TBL] [Abstract][Full Text] [Related]
20. Characterization and quantitation of apolipoproteins A-I and E of normal and cholesterol-fed guinea pigs.
Guo LS; Hamilton RL; Kane JP; Fielding CJ; Chen GC
J Lipid Res; 1982 May; 23(4):531-42. PubMed ID: 7182951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
